Skip to main content
Clinical Trials/ACTRN12613000008729
ACTRN12613000008729
Completed
未知

Diet and Lifestyle interventions for glycemic control, cardiometabolic and cognitive health in type 2 diabetes.

Prof Jon Buckley (Centre Director)0 sites60 target enrollmentStarted: January 4, 2013Last updated:

Overview

Phase
未知
Status
Completed
Sponsor
Prof Jon Buckley (Centre Director)
Enrollment
60

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Open (masking not used)

Eligibility Criteria

Ages
18 Years to 65 Years (—)
Sex
All

Inclusion Criteria

  • Poorly controlled type 2 diabetes (with a HbA1c level between 7\-10%); overweight or obese (BMI, 25 kg/m2 and above); omnivorous; English as a First Language (different cognitive processes are applied when learning words from a non\-native language)

Exclusion Criteria

  • Subjects who report one of the following: known proteinuria, malignancy; liver, kidney, cardiovascular, respiratory, or gastrointestinal disease; uncontrolled hypertension; previous stroke; pregnancy or lactating; smoker (or smoking in the last 6months); musculoskeletal injury or joint or peripheral vascular disease sufficient to impede exercise; use of appetite suppressants or Orlistat (Xenical); retinopathy; inability to consume a high meat protein diet for 6 months; actively undertaking a weight loss program or report their weight is greater than 135kg (exceeds the capability for DEXA scanning to assess body composition); unable to participate in the trial for 6 months; taking medications for, or had a history of head/brain, neurological or psychiatric conditions, scores of \<13 on the DemTect indicating mild cognitive impairment or dementia will be excluded.

Investigators

Sponsor
Prof Jon Buckley (Centre Director)

Similar Trials